What to Expect From AbbVie's Q3 2025 Earnings Report

North Chicago, Illinois-based AbbVie Inc. (ABBV) focuses on creating medicines and solutions that address complex health issues and enhance people's lives through its core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics, and more. With a market cap of $408.5 billion, AbbVie operates as one of the largest biopharmaceutical companies in the world. The pharma giant is gearing up to announce its third-quarter results before the market opens on Friday, Oct. 31. Ahead of the event, a ...